Craig-Hallum Remains a Hold on Ironwood Pharma (IRWD)
In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Hold rating on Ironwood Pharma. The company’s shares opened today at $0.92.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Knickerbocker covers the Healthcare sector, focusing on stocks such as MiMedx Group, Indivior, and Celcuity. According to TipRanks, Knickerbocker has an average return of 16.2% and a 52.88% success rate on recommended stocks.
In a report released today, TR | OpenAI – 4o also reiterated a Hold rating on the stock with a $1.00 price target.
IRWD market cap is currently $130.3M and has a P/E ratio of -17.74.
Based on the recent corporate insider activity of 31 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of IRWD in relation to earlier this year. Most recently, in May 2025, Thomas Mccourt, the CEO of IRWD sold 13,353.00 shares for a total of $7,744.74.
